Marcos González Diaz - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Marcos González Diaz

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Frontiers in Microbiology|November 29, 2023

Collaborative cytometric inter-laboratory ring test for probiotics quantificationPeter Lüttge Jordal, Marcos González Diaz, Carlotta Morazzoni, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009

Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemiaFrancesc Bosch, Pau Abrisqueta, Neus Villamor, et al.

Frontiers in Medicine|September 28, 2020

Measures to Maintain a SARS-CoV-2 Negative Inpatient Hematological Unit in the Midst of the COVID-19 PandemicAlmudena Cabero-Martínez, Fermín Sánchez-Guijo, Lucía López-Corral, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Frontiers in Microbiology|November 29, 2023

Collaborative cytometric inter-laboratory ring test for probiotics quantificationPeter Lüttge Jordal, Marcos González Diaz, Carlotta Morazzoni, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009

Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemiaFrancesc Bosch, Pau Abrisqueta, Neus Villamor, et al.

Frontiers in Medicine|September 28, 2020

Measures to Maintain a SARS-CoV-2 Negative Inpatient Hematological Unit in the Midst of the COVID-19 PandemicAlmudena Cabero-Martínez, Fermín Sánchez-Guijo, Lucía López-Corral, et al.

Pageof 1